Abstract
Purpose:
To synthesize a new series of 5-(3,4-dichlorophenyl)-3-[(4-substitutedpiperazin-1-yl)methyl]-1,3,4-oxadiaxole-2-thiones
for their anti-inflammatory activity.
Methods:
The title compounds synthesized by Mannich reaction of prepared 5-(3,4-dichlorophenyl)-1,3,4-oxadiazole-2-thione
and appropriate substituted piperazine derivatives. The structures of the compounds
were confirmed by IR, NMR and elemental analyses. The newly synthesized compounds
were evaluated for their anti-inflammatory and ulcerogenic activities.
Results:
Most of the compounds were found to have significant anti-inflammatory profile in
carrageenan footpad edema test. The compounds showed anti-inflammatory activity ranging
from 30.6% to 57.8% inhibition.
Conclusion:
The compounds 5b, 5f, 5i, 5p and 5r showed most prominent anti-inflammatory activity
with low gastric ulceration incidence than the reference drug indomethacine. These
compounds could serve as lead molecules for further modifications.
Key words
anti-inflammatory drugs - 1,3,4-oxadiazole-2-thiones - gastric ulceration - piperazine